Frequency and Risk Factors of Acute Myeloid Leukemia

Launched by ASSIUT UNIVERSITY · Mar 15, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how common acute myeloid leukemia (AML) is and identifying factors that might increase the risk of developing this type of cancer. The researchers at Assiute University Hospital want to find out if known risk factors, as well as any new ones, are linked to a higher occurrence of AML. The trial is not yet recruiting participants, but when it starts, it will welcome adults aged 18 and older who have been diagnosed with AML according to specific medical guidelines.

To be eligible, participants must not have other types of leukemia. Those who join the study can expect to share their medical history and possibly undergo tests to help researchers gather the information they need. This study is important because understanding the frequency and risk factors of AML could lead to better prevention and treatment strategies in the future. If you or someone you know might be interested in participating, it’s a chance to contribute to valuable research in this area.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult Patients(above 18 years) diagnosed as acute myeloid leukemia according to WHO diagnostic criteria
• Exclusion Criteria:
• • Patients with other types of leukemia